Premium
O‐010: A phase 2 dose‐optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—analysis from the LOWR HDV‐2 study using the robogene ® real‐time qPCR HDV RNA assay
Publication year - 2018
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.08_12922
Subject(s) - hepatitis d , chronic hepatitis , ritonavir , citation , covid-19 , medicine , virology , library science , computer science , human immunodeficiency virus (hiv) , viral load , hepatitis b virus , antiretroviral therapy , virus , hbsag , disease , infectious disease (medical specialty)